Reuters logo
BRIEF-Actelion gets Japanese nod for epoprostenol "ACT"
February 18, 2013 / 4:41 PM / 5 years ago

BRIEF-Actelion gets Japanese nod for epoprostenol "ACT"

ZURICH, Feb 18 (Reuters) - Actelion Ltd : * Actelion Pharmaceuticals Ltd : Actelion obtains marketing approval for

epoprostenol “ACT” in Japan

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below